Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 15/20 | 0.43 |
| ▸ | NOS1 | P29475 | 15/20 | 0.43 |
| ▸ | NOS2 | P35228 | 12/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL8867335 | 0.98 | NOS3 (0.45) | NOS3NOS1NOS2CA1CA2 | |
| SCHEMBL5831598 | 0.78 | CA1 (0.38) | NOS3NOS1CA1CA2CA4 | |
| SCHEMBL11879318 | 0.77 | HTR3E (0.56) | NOS3NOS1NOS2CA1CA2 | |
| SCHEMBL14938204 | 0.77 | NOS3 (0.69) | NOS3NOS1NOS2MEN1NPC1 | |
| SCHEMBL5831997 | 0.74 | CA1 (0.35) | NOS3NOS1NOS2CA1CA2 | |
| SCHEMBL21595593 | 0.74 | KMT2A (0.44) | CA1CA2CA4CA9MEN1 | |
| SCHEMBL11159562 | 0.72 | NOS3 (0.55) | NOS3NOS1NOS2 | |
| SCHEMBL10189842 | 0.71 | NOS1 (0.64) | NOS3NOS1NOS2MEN1KMT2A | |
| SCHEMBL7403875 | 0.71 | NOS1 (0.64) | NOS3NOS1NOS2MEN1KMT2A | |
| Iodide SCHEMBL8621155 | 0.69 | NOS1 (0.66) | NOS3NOS1NOS2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5998399-A | Guanidine derivatives useful in therapy as inhibitors of nitric oxide synthetase | ASTRA AKTIEBOLAG (SE) | 1999-12-07 | — | — | US | disclosed |
| EP-0690851-B1 | GUANIDINE DERIVATIVES USEFUL IN THERAPY | ASTRA AB (SE) | 1999-05-19 | — | — | EP | disclosed |
| US-5885985-A | Guanidine derivatives useful in therapy | ASTRA AKTIEBOLAG (SE) | 1999-03-23 | — | — | US | disclosed |
| EP-0690851-A1 | GUANIDINE DERIVATIVES USEFUL IN THERAPY | Astra Aktiebolag (SE) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994021621-A1 | GUANIDINE DERIVATIVES USEFUL IN THERAPY | ASTRA AKTIEBOLAG (SE) | 1994-09-29 | — | — | WO | disclosed |